If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

Related content
Volume 11, Number 6, September 2012

< previous issue | all issues | next issue >


Favourites:Add to Favourites

Free Content Conference Report [IANR V and 9th GCNN Conference with 4th ISCITT Symposium]
pp. 643-646(4)
Authors: Leng, Zikuan; Guo, Lei; Shanker Sharma, Hari; Huang, Hongyun; He, Xijing

Favourites:Add to Favourites

From A1 to A3 en passant Through A2A Receptors in the Hippocampus: Pharmacological Implications
pp. 652-663(12)
Authors: M. Sebastiao, Ana; F. Ribeiro, Filipa; A. Ribeiro, Joaquim

Favourites:Add to Favourites
Favourites:Add to Favourites

P2X1 and P2X2 Receptors in the Central Nervous System as Possible Drug Targets
pp. 675-686(12)
Authors: Hausmann, Ralf; Schmalzing, Gunther

Favourites:Add to Favourites

Regulation of P2X3 Receptor Structure and Function
pp. 687-698(12)
Authors: Fabbretti, Elsa; Nistri, Andrea

Favourites:Add to Favourites

P2X4 Receptors of Microglia in Neuropathic Pain
pp. 699-704(6)
Authors: Inoue, Kazuhide; Tsuda, Makoto

Favourites:Add to Favourites

P2X7 Receptors: Channels, Pores and More
pp. 705-721(17)
Authors: Volonte, C.; Apolloni, S.; D. Skaper, S.; Burnstock, G.

Favourites:Add to Favourites

P2Y Receptors in the Mammalian Nervous System: Pharmacology, Ligands and Therapeutic Potential
pp. 722-738(17)
Authors: A. Weisman, Gary; T. Woods, Lucas; Erb, Laurie; I. Seye, Cheikh

Favourites:Add to Favourites

Anti-Parkinsonian Effects of Nurr1 Activator in Ubiquitin-Proteasome System Impairment Induced Animal Model of Parkinson’s Disease
pp. 768-773(6)
Authors: Zhang, Zhen; Li, Xuping; Xie, Wen-jie; Tuo, Houzhen; Hintermann, Samuel; Jankovic, Joseph; Le, Weidong

Favourites:Add to Favourites

Mn (III) Tetrakis (4-Benzoic Acid) Porphyrin Protects Against Neuronal and Glial Oxidative Stress and Death After Spinal Cord Injury
pp. 774-790(17)
Authors: Valluru, Lokanatha; Diao, Yao; E. Hachmeister, Jorge; Liu, Danxia

Favourites:Add to Favourites

Methylene Blue Inhibits the Function of α7-Nicotinic Acetylcholine Receptors
pp. 791-800(10)
Authors: S. Al Mansouri, Abdulla; E. Lorke, Dietrich; M. Nurulain, Syed; Ashoor, Abrar; Yang Keun-Hang, Susan; Petroianu, Georg; Isaev, Dmytro; Oz, Murat

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more